Mark Skousen
Forecasts & Strategies
Jim Powell
Global Changes & Opportunities Report
Ian Wyatt
Top Stock Insights
J. Royden Ward
Cabot Benjamin Graham Value Letter

Top stocks 2013: Aflac & Thermo Fisher


Bookmark and Share
by Richard Moroney, editor Dow Theory Forecasts

Chuck CarlsonAflac (AFL), a U.S.-based insurer that draws nearly 80% of its sales from Japan, is our top pick for 2013 for yield-oriented investors.

For capital gains, our top idea for the coming year is Thermo Fisher Scientific (TMO), which furnishes research labs with instruments, equipment, flasks, solvents, and analytical software.

Aflac generated record highs for revenue, operating cash flow, and earnings per share in the last 12 months. Growth seems likely to continue in 2013, though at a slower pace.

The stock has returned more than 25% in 2012 but still looks cheap at just nine times trailing earnings, 48% below its 10-year average P/E.


Aflac also looks attractive relative to the 10-year norm based on its 2.6% dividend yield, and the dividend has been raised in 30 consecutive years.

In our Quadrix stock-rating system, all six of Aflac's category scores rank in the top 25% of our research universe, and the Overall score is the maximum of 100. Aflac, yielding 2.6%, is a Focus List Buy and a Long-Term Buy.

For capital gains, our top idea for the coming year is Thermo Fisher Scientific, which furnishes research labs with instruments, equipment, flasks, solvents, and analytical software.

Thermo Fisher Scientific's free cash flow rose 34% over the past year to $1.63 billion, and management seeks to return half of free cash flow to investors through stock buybacks and dividends.

Budget constraints could put pressure on Thermo Fisher's academic and government research clients (25% of sales). However, the stock's valuation -- just 14 times trailing earnings, a 31% discount to its three-year average, discounts those budget worries.

In our Quadrix stock-rating system, all six of the stock's category scores exceed 50, contributing to an Overall rank of 92. Thermo Fisher is a Focus List Buy and a Long-Term Buy.

Learn more about this financial newsletter at Richard Moroney's Dow Theory Forecasts.

Related articles

Advertisement
Banner
News Flash

US Natural Gas ETF: On a roll
by Doug Fabian, editor Successful Investing

One area I think is ready for a new buy is natural gas. After experiencing a sharp decline from November through early January, natural gas prices have been on a roll.


Read more...

 

Split buys? HOMB and Noble Energy
by Neil Macneale, editor 2-for-1 Stock Split Newsletter

Each month, we add one stock to our model portfolio based upon those companies that have announced 2-for-1 stock splits; after a meager number of splits over the past year, we have a nice collection of six splits elect from this month.


Read more...


   

WisdomTree targets global bonds
by Mark Salzinger, editor The Investor's ETF Report

While most investors diversify the equity portions of their portfolio with allocations to foreign stocks, few diversify their bond holdings internationally. WisdomTree recently introduced the first ETF to invest in a truly global portfolio of corporate bonds.


Read more...

 

Express Scripts: Obamacare buy
by J. Royden Ward, editor Cabot Benjamin Graham Value Investor

I am attracted to healthcare stocks because the confusion surrounding “ObamaCare” has held healthcare stock prices back. I think Express Scripts (ESRX) is very likely to shine in 2013.


Read more...

 

Hodges: High conviction funds
by Walter Frank, editor MoneyLetter

Over the last two months, Hodges Fund (HDPMX) has made a strong run to the top echelons of our domestic stock fund rankings. And one of its siblings, Hodges Small Cap (HDPSX) has been within the top decline of the small blend category from 2009 through last year, and is in the top 20% this year.


Read more...

 

United Natural: A play on Whole Foods
by Mark Skousen, editor Hedge Fund Trader Alert

We’ve recommended Whole Foods Market (WFM) from time to time, and the stock has moved up sharply in the past three years, but I’d like to suggest an alternative -- one of Whole Foods’ primary suppliers, United Natural Foods (UNFI).


Read more...

 

Timing expert eyes India
by Sy Harding, editor Street Smart Report

The money flow and momentum reversals in India's Bombay Index have now been enough to trigger buy signals on intermediate-term indicators. With this new buy signal, we have added a position in the iShares India 50 ETF (INDY) to our portfolio.


Read more...

 

Value investor goes with Guess
by Charles Mizrahi, editor Hidden Values Alert

Guess?, Inc. (GES) is a holding in our special situation portfolio; its strong product quality has created brand name recognition and a loyal consumer following.


Read more...

 

MGAM: Bingo, lotteries, casinos
by Jim Oberweis, Jr., editor The Oberweis Report

Multimedia Games Holding Company (MGAM) makes innovative gaming systems for Native American and commercial casino operators in North America, lottery operators, and charity and commercial bingo operators.


Read more...

 

Fidelity expert: Bowers' bond bets
by Jack Bowers, editor Fidelity Monitor & Insight

If you’ve been worried that the bond market might take a big hit, you can relax. Indeed, while bond funds may lag stock funds over the next 5-10 years, they still have a decent shot at keeping up with inflation, and they remain an excellent way to cut risk in a blended portfolio.


Read more...

 



Banner



Close
Select Offer: Schwab Options Market Commentary